Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells

被引:217
|
作者
Iovino, L. [1 ]
Tremblay, M. E. [2 ]
Civiero, L. [1 ,3 ]
机构
[1] Univ Padua, Dept Biol, Padua, Italy
[2] Univ Victoria, Div Med Sci, Victoria, BC, Canada
[3] IRCCS San Camillo Hosp, Venice, Italy
关键词
Parkinson's disease; Glutamate-induced excitotoxicity; Inflammation; Astrocytes; Microglia; TUMOR-NECROSIS-FACTOR; ANTIPORTER SYSTEM X(C)(-); TIME-DEPENDENT CHANGES; ALPHA-SYNUCLEIN; LRRK2; G2019S; MOUSE MODEL; MICROGLIAL ACTIVATION; L-DOPA; REACTIVE ASTROCYTES; RECEPTORS PROTECTS;
D O I
10.1016/j.jphs.2020.07.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate transmission efficiency depends on the correct functionality and expression of a plethora of receptors and transporters, located both on neurons and glial cells. Of note, glutamate reuptake by dedicated transporters prevents its accumulation at the synapse as well as non-physiological spillover. Indeed, extracellular glutamate increase causes aberrant synaptic signaling leading to neuronal excitotoxicity and death. Moreover, extrasynaptic glutamate diffusion is strongly associated with glia reaction and neuroinflammation. Glutamate-induced excitotoxicity is mainly linked to an impaired ability of glial cells to reuptake and respond to glutamate, then this is considered a common hallmark in many neurodegenerative diseases, including Parkinson's disease (PD). In this review, we discuss the function of astrocytes and microglia in glutamate homeostasis, focusing on how glial dysfunction causes glutamate-induced excitotoxicity leading to neurodegeneration in PD. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.
引用
收藏
页码:151 / 164
页数:14
相关论文
共 50 条
  • [31] Glial cells and Parkinson's disease
    Hirsch, EC
    JOURNAL OF NEUROLOGY, 2000, 247 (Suppl 2) : 58 - 62
  • [32] Glial cells and Parkinson’s disease
    E. C. Hirsch
    Journal of Neurology, 2000, 247 : II58 - II62
  • [33] GLIAL CELLS AND PARKINSON'S DISEASE
    Tripanichkul, Wanida
    Charoensuppaperch, Em-orn
    JOURNAL OF HEALTH RESEARCH, 2005, 19 (02) : 183 - 195
  • [34] Glutamate-induced p38 MAPK activation in Bergmann glial cells
    Zepeda, R. C.
    Hernandez-Kelly, L. C.
    Gonzalez-Mejia, M. E.
    Castelan, F.
    Ortega, A.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 108 - 109
  • [35] Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells
    Grima, G
    Benz, B
    Do, KQ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (11) : 2248 - 2258
  • [36] Paracrine Neuroprotective Effects of Neural Stem Cells on Glutamate-Induced Cortical Neuronal Cell Excitotoxicity
    Geranmayeh, Mohammad Hossein
    Baghbanzadeh, Ali
    Barin, Abbas
    Salar-Amoli, Jamileh
    Dehghan, Mohammad Mehdi
    Rahbarghazi, Reza
    Azari, Hassan
    ADVANCED PHARMACEUTICAL BULLETIN, 2015, 5 (04) : 515 - 521
  • [37] Neuroprotective effect of a dietary supplement against glutamate-induced excitotoxicity in retina
    Kurose, Takahiro
    Sugano, Eriko
    Sugai, Akihisa
    Shiraiwa, Raki
    Kato, Mariyo
    Mitsuguchi, Yoko
    Takai, Yoshihiro
    Tabata, Kitako
    Honma, Yoichi
    Tomita, Hiroshi
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (08) : 1231 - 1237
  • [38] Neuroprotective effect of a dietary supplement against glutamate-induced excitotoxicity in retina
    Takahiro Kurose
    Eriko Sugano
    Akihisa Sugai
    Raki Shiraiwa
    Mariyo Kato
    Yoko Mitsuguchi
    Yoshihiro Takai
    Kitako Tabata
    Yoichi Honma
    Hiroshi Tomita
    International Journal of Ophthalmology, 2019, 12 (08) : 1231 - 1237
  • [39] Neuroprotective effect of Hydrocotyle sibthorpioides against monosodium glutamate-induced excitotoxicity
    Hazarika, Iswar
    Mukundan, Geetha Kannoth
    Sundari, P. Sivakami
    NATURAL PRODUCT RESEARCH, 2022, 36 (23) : 6156 - 6159
  • [40] Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action
    Swartz, Michael M.
    Linn, David M.
    Linn, Cindy L.
    NEUROPHARMACOLOGY, 2013, 73 : 111 - 121